Photodynamic Therapy Devices Market Size to be Valued at USD 15.8 Billion till 2034; Market is Driven by the Expanding Applications in Healthcare

Photodynamic therapy devices market refers to the development, manufacturing and distribution of medical devices that use photodynamic therapy as a treatment procedure. Photodynamic therapy is combined with laser and photosensitizing agents to treat various medical conditions such as oncology and non-oncology applications. It is effective for treating precancerous skin lesions, such as acne and psoriasis by treating abnormal cells and reduce inflammation, thus it is rising preference for non-invasive treatment.

Photodynamic Therapy Devices Market Segmentation Analysis:

By Product	Diode Lasers, Disposable Fiber Optic Light Delivery Devices, and LED-based Devices
By Application	Cancer, Actinic Keratosis, Acne, Psoriasis, and Others
By End-User	Hospitals, Clinics & Dermatology Centers, and Others

Photodynamic Therapy Devices Market Report Highlights:

• Photodynamic therapy devices market size was worth USD 2.1 Billion in 2024.
• The market is anticipated to reach USD 15.8 Billion by 2034, expanding at a CAGR of 24.8%.
• On the basis of product, diode lasers segment is expected to hold the largest share in target market.
• Based on application, cancer segment is expected to drive market growth.
• Based on end-user, hospitals segment dominates in target market.
• Accordance to region, North America holds the largest market share in focused market.

Photodynamic Therapy Devices Market Dynamics:

Growing Factor	Challenge Factor	Market Trend
Growing Demand for Aesthetic and Skin Care Treatment	Limited Effectiveness for All Cancer Types	Expanding Research and Development

Photodynamic Therapy Devices Market Key Highlights

In February 2021, Topical Actinic Keratosis Treatment introduced in the U.S. Almirall has announced that tirbanibulin, a new microtubule inhibitor in the form of Klisyri by Almirall, is introduced for the topical treatment of actinic keratosis on the face or scalp, according to a company press release.

Photodynamic Therapy Devices Market Report Analysis:

·For instance, in June 2024, Biofrontera Inc. announced 100 RhodoLED XL Machines placed in the U.S. market. This device approved from FDA for the use with Ameluz gel for photodynamic therapy (PDT) of actinic keratoses. The RhodoLED XL features more LED panels than its predecessor BF-RhodoLED, enabling treatment of larger surface areas in a single session. Physicians can use up to 3 tubes of Ameluz in one treatment, to maximizing the benefits of the larger illumination area.

Browse ∼40 market data tables and ∼35 figures through ∼140 slides and in-depth TOC on “Photodynamic Therapy Devices Market, By Product (Diode Lasers, and Disposable Fiber Optic Light Delivery Devices, and LED-based Devices), Application (Cancer, Actinic Keratosis, Acne, Psoriasis, and Others), End-User (Hospitals, Clinics & Dermatology Centers, and Others), and Region - Trends, Analysis, and Forecast till 2034”

For more insights into the Photodynamic Therapy Devices Market and its future trends, visit the link: https://www.prophecymarketinsights.com/market_insight/photodynamic-therapy-devices-market-5531

Competitive Landscape of Photodynamic Therapy Devices Market:

The key players operating in the photodynamic therapy devices market are GALDERMA, Biofrontera AG, Sun Pharmaceuticals Industries Ltd., LUMIBIRD Groups (Quantel Medical), Modulight Corporation, Quest PharmaTech, Inc., Theralase Technologies Inc., and SUS Advancing Tecchnology CO., Ltd.

Company Name	GALDERMA
Headquarter	Zug, Switzerland
CEO	Flemming Ørnskov
Employee Count (2024)	6,500 Employees